Can ‘Big Data’ Help Increase Drug Safety? | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Can ‘Big Data’ Help Increase Drug Safety?

October 9, 2013
by John DeGaspari
| Reprints
Researchers use an EHR database to reduce adverse effects

Using the Food and Drug Administration's Adverse Event Reporting System (FAERS), a hospital electronic health records database, and an animal model, a team of researchers at the Icahn School of Medicine at Mount Sinai report that by adding a second drug to the diabetes drug rosiglitazone, adverse events dropped enormously. That suggests that drugs could be repurposed to improve drug safety, including lowering the risk of heart attacks. The research is published online Oct. 9 in the journal Science Translational Medicine.

 “Big data systems have a wealth of data, and when studied appropriately, can point to potentially safer combinations,” said Ravi Iyengar Ph.D., professor of pharmacology and director of the Systems Biology Center at the Icahn School of Medicine at Mount Sinai. He said that findings from big data analyses, although preliminary, can point to potentially safer combinations that can subsequently be tested in clinical trial. “We may be able to use FDA-approved drugs to prevent adverse events,” he said

In this study, investigators studied how drug combinations act through networks within cells, focusing on the diabetes drug rosiglitazone, an effective drug in controlling blood glucose. However, rosiglitazone has a serious side effect, increased heart attacks, which have restricted its use markedly. Investigators analyzed data from the FDAERS to see if second drugs could lower the rate heart attacks, and compared their results with Mount Sinai's electronic health records system. They found that the drug exanatide, often given along with rosiglitazone to get better control of blood glucose, also very substantially reduced the heart attack rate in rosiglitazone users. Iyengar’s team also found nearly 19,000 other drug combinations in the FDA database, where the second drug appears to reduce a wide range of side effects of the first drug.

The research team said that that the results are a valid starting point for developing clinical trials of safer drug combinations, and urged researchers and clinicians to contribute to big databases, such as the FDA’s Adverse Event Reporting System.

 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Trump will Nominate Acting VA Secretary Wilkie for Permanent Position

Just a day after the Department of Veterans Affairs (VA) and Cerner inked their $10 billion EHR (electronic health record) deal, President Trump said he would be nominating Acting VA Secretary Robert Wilkie for the permanent position.

ONC Names API Server Showdown Stage 2 Winner

The Office of the National Coordinator for Health Information Technology (ONC) has named 1UpHealth as the Stage 2 winner of the “Secure API Server Showdown” challenge.

EHNAC Developing Trusted Exchange Accreditation Program

To align with the Trusted Exchange Framework and Common Agreement, the Electronic Healthcare Network Accreditation Commission, a nonprofit standards development organization and accrediting body, is working with other organizations to establish a new Trusted Exchange Accreditation Program.

Lawmakers Demand New VA CIO, Citing “Malign Neglect” on EHR Project

A group of Democratic federal lawmakers, five senators and six members of Congress, are calling out the U.S. Department of Veterans Affairs (VA) for what they call “malign neglect” in the agency’s efforts to achieve electronic health record (EHR) modernization.

Medical Record Access Proves Costly for Some Patients, GAO Report Finds

Federal law requires healthcare providers to give patients access to their medical records, but according to a new GAO report, some patients believe they’re being charged too much to access their records.

Parkland’s Innovation Bridge Takes ‘Genius Bar’ Approach to Digital Health Apps

Taking inspiration from the Apple Genius Bar and Ochsner Health System’s O Bar, the Dallas-based Parkland Center for Clinical Innovation in collaboration with Parkland Health & Hospital System has opened an “Innovation Bridge” to assist patients with health-related apps.